Caricamento...
CHEMOTHERAPY: A new standard combination for recurrent ovarian cancer?
Ovarian cancer that recurs more than 6 months following primary chemotherapy can respond to many different drugs, but retreatment with a combination of carboplatin and paclitaxel has become a standard of care. A combination of pegylated liposomal doxorubicin and carboplatin may provide a slightly bu...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2010
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2956193/ https://ncbi.nlm.nih.gov/pubmed/20877420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2010.152 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|